Teevodar Cream
FDA Label NDC 69435-1301

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Peer Pharm Ltd. for the product Teevodar (NDC 69435-1301). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient, purpose, uses, warnings, directions, inactive ingredients, product label, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Active Ingredient

Allantoin 0.5%

Purpose

Skin Protectant

Uses

Temporarily protects minor cuts scrapes burns

Warnings

  • For external use only
  • When using this product do not get into eyes
  • Stop use and ask a doctor if 
  • contition worsens 
  • symptoms last more than 7 days or clear up and occur again within a few days
  • Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

  • Apply as needed. 
  • Children under 12 years of age: consult a doctor

Inactive Ingredients

Ceteareth-20, Cetearyl alcohol, Cetyl alcohol, ethylhexylglycerin, Hamamelis virginiana (witch hazel) leaf extract, Isopropyl myristate, Lanolin, Mineral oil, Origanum vulgare (oregano) leaf extract, Petrolatum, Phenoxyethanol, Purified water, Rosmarinus officinalis (rosemary) leaf extract, Zea mayes (corn) oil

Product Label

Image Description (Product Label)

Image Description (Product Label)

* Please review the disclaimer below.